Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. R. Batstra"'
Autor:
Frans Boomsma, Henk-Jan Aanstoot, A. H. Van Den Meiracker, S. Winkel, G. J. Bruining, M. R. Batstra, A. J. Man In 'T Veld
Publikováno v:
Diabetologia. 42:233-237
Plasma semicarbazide-sensitive amine oxidase is raised in patients with Type I (insulin-dependent) diabetes mellitus. It has been suggested that this enzyme is involved in the development of microvascular damage through its ability to convert amines
Publikováno v:
Annals of Medicine. 29:453-460
The first large-scale (secondary) intervention trials have been initiated in first-degree family members of patients with insulin-dependent diabetes mellitus (IDDM). Within a few years, data from these studies may suggest that intervention is possibl
Autor:
G.-R. Burmester, Twj Huizinga, A.H.M. van der Helm-van Mil, L. E. Bakker‐Jonges, Hans Scherer, Tore K Kvien, M.D. Mjaavatten, René E. M. Toes, Hans Bastian, Jacqueline Detert, M. P. M. van der Linden, M. R. Batstra
Publikováno v:
Arthritis and Rheumatism, 63(5), 1190-1199
Arthritis & Rheumatism; Vol 63
Arthritis and Rheumatism, 63(5), 1190-9
Arthritis & Rheumatism
Arthritis & Rheumatism; Vol 63
Arthritis and Rheumatism, 63(5), 1190-9
Arthritis & Rheumatism
Objective Recently, new classification criteria for rheumatoid arthritis (RA) have been devised by methodology that used first a quantitative approach (data from databases), then a qualitative approach (consensus; based on paper patients), and finall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3323753577b6c54f292c38c44d649430
https://hdl.handle.net/1887/118734
https://hdl.handle.net/1887/118734
Publikováno v:
Diabetes Care, 20(4), 642-644. American Diabetes Association Inc.
OBJECTIVE To investigate whether the presence of GAD antibodies at onset of IDDM correlates to a more aggressive rate of β-cell destruction after clinical onset. RESEARCH DESIGN AND METHODS We studied GAD antibodies at onset of disease, after 1 year
Publikováno v:
Clinical laboratory. 47(9-10)
The clinical manifestation of type 1 diabetes is the endpoint of a long-lasting immune-mediated destruction process of the B-cells. Autoantibodies originating from this process can be applied in the diagnosis and clinical discrimination of autoimmune
Autor:
F, Winnock, M R, Christie, M R, Batstra, H J, Aanstoot, I, Weets, K, Decochez, P, Jopart, D, Nicolaij, F K, Gorus
Publikováno v:
Diabetes care. 24(7)
To study the association of autoantibodies against a 38-kDa glycated islet cell membrane-associated (GLIMA) protein with (pre)type 1 diabetes, patient characteristics, and other immune and genetic markers of the disease and to evaluate the possible a
Autor:
G J, Bruining, M R, Batstra
Publikováno v:
Diabetes, nutritionmetabolism. 12(2)
Publikováno v:
Journal of medical virology. 59(2)
Type I diabetes mellitus results from the autoimmune destruction of insulin producing beta cells in the pancreas. Certain viral infections, especially those caused by coxsackie B viruses and related enteroviruses, have been associated with the develo
Publikováno v:
Diabetologia. 48:1941-1942